Page last updated: 2024-09-05

anidulafungin and micafungin

anidulafungin has been researched along with micafungin in 168 studies

Compound Research Comparison

Studies (anidulafungin)	Trials (anidulafungin)	Recent Studies (post-2010) (anidulafungin)	Studies (micafungin)	Trials (micafungin)	Recent Studies (post-2010) (micafungin)
568	33	331	1,015	85	604

Research

Studies (168)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	52 (30.95)	29.6817
2010's	99 (58.93)	24.3611
2020's	17 (10.12)	2.80

Authors

Authors	Studies
Jacobsen, MD; Odds, FC; Whyte, JA	1
Garcia-Effron, G; Hsu, MJ; Kahn, JN; Marr, KA; Park, S; Perlin, DS	1
Balashov, S; Delmas, G; Garcia-Effron, G; Paderu, P; Park, S; Perlin, DS	1
Albert, N; Chamilos, G; Kontoyiannis, DP; Lewis, RE	1
Garcia-Effron, G; Park, S; Perlin, DS; Rocha, EM	1
Odabasi, Z; Ostrosky-Zeichner, L; Paetznick, V; Rex, JH	1
Antachopoulos, C; Meletiadis, J; Roilides, E; Sein, T; Walsh, TJ	1
Alastruey-Izquierdo, A; Almirante, B; Cuenca-Estrella, M; Gomez-Lopez, A; Pahissa, A; Rodriguez, D; Rodriguez-Tudela, JL	1
Chapman, SW; Cleary, JD; Garcia-Effron, G; Perlin, DS	1
Lombardo, F; Obach, RS; Waters, NJ	1
Edlind, TD; Garcia-Effron, G; Katiyar, SK; Park, S; Perlin, DS	1
Damle, B; Dowell, J; Stogniew, M	1
Chu, CC; Hsueh, PR; Ruan, SY	1
Alastruey-Izquierdo, A; Castelli, MV; Cuenca-Estrella, M; Cuesta, I; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	1
Lewis, JS; Patterson, TF; Thompson, GR; Vallor, AC; Villareal, NC; Wiederhold, NP	1
Garcia-Effron, G; Grabinski, JL; Lee, SA; Perlin, DS; Wiederhold, NP	1
Garcia-Effron, G; Kontoyiannis, DP; Lewis, RE; Perlin, DS	1
Garcia-Effron, G; Park, S; Perlin, DS	1
Alspaugh, JA; Fortwendel, JR; Juvvadi, PR; Perfect, BZ; Perfect, JR; Pinchai, N; Steinbach, WJ	1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Lass-Flörl, C; Perkhofer, S; Rodriguez-Tudela, JL	1
Dimopoulos, G; Falagas, ME; Velegraki, A	1
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzon, A; Rodriguez-Tudela, JL	1
Jacobson, MJ; Patel, R; Piper, KE; Steckelberg, JM; Steckelberg, KE	1
Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Valentín, A	1
Cleary, JD; Garcia-Effron, G; Lee, S; Park, S; Perlin, DS	1
Chittick, P; Delashmitt, B; Evans, J; Palavecino, EL; Peacock, JE	1
Guarro, J; Mariné, M; Pastor, FJ; Pontón, J; Quindós, G; Sahand, IH	1
Canton, E; Espinel-Ingroff, A; Martín-Mazuelo, E; Peman, J	1
Cantón, E; del Castillo, L; Espinel-Ingroff, A; Pemán, J	1
Bonilla, H; Chua, DJ; DiPersio, J; Garcia-Effron, G; Ghannoum, M; Perlin, DS; Tomada, JR	1
Bakker-Woudenberg, IA; Fahal, AH; van Belkum, A; van de Sande, WW	1
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Pfaller, MA; Woosley, LN	2
Andes, D; Bohrmuller, J; Diekema, DJ; Lepak, A; Marchillo, K; Pfaller, MA	1
Alastruey-Izquierdo, A; Cuenca-Estrella, M; Cuesta, I; Rodriguez-Tudela, JL; Walther, G	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Liu, W; Wang, S; Yuan, L	1
Chiou, CC; Groll, AH; Walsh, TJ	1
Graybill, JR	1
Arathoon, EG	1
Espinel-Ingroff, A	1
Darouiche, RO	1
Theuretzbacher, U	1
Steinbach, WJ	1
Baker, CJ; Pannaraj, PS; Walsh, TJ	1
Morrison, VA	1
Bennett, JE	1
Morris, MI; Villmann, M	1
Graninger, W; Joukhadar, C; Presterl, E; Wagner, C	1
Cappelletty, D; Eiselstein-McKitrick, K	1
Khachikian, D; Kim, R; Reboli, AC	1
Boyken, L; Diekema, DJ; Hollis, RJ; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S	2
Fleischhacker, M; Radecke, C; Ruhnke, M; Schulz, B	1
Scheinfeld, N	1
Edwards, JE; Fu, Y; Gebremariam, T; Ibrahim, AS; Spellberg, B	1
Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Holliday, NM; Killian, SB; Knapp, CC; Messer, SA; Miskov, A; Pfaller, MA; Ramani, R	1
Alexander, BD; Andes, D; Brown, SD; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Knapp, CC; Ostrosky-Zeichner, L; Pfaller, MA; Rex, JH; Sheehan, DJ; Walsh, TJ	1
Baxa, D; Buhari, M; Chandra, J; Chen, A; Ghannoum, MA; Golembieski, A; Mukherjee, PK; Vazquez, JA	1
Martín Mazuelos, E; Rodríguez-Tudela, JL	1
Balcer, HE; Chahine, EB; Sucher, AJ	1
Dirks, D; Hazen, KC; Masuoka, J	1
Arendrup, MC; Cuenca-Estrella, M; Garcia-Effron, G; Lass-Flörl, C; Lopez, AG; Perlin, DS; Rodriguez-Tudela, JL	1
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Kroeger, J; Messer, SA; Pfaller, MA; Tendolkar, S; Turnidge, J	1
Bal, AM	1
Cantón, E; Castro, C; González, A; González, MT; Martín-Mazuelos, E; Martos, AI; Pemán, J; Romero, A; Serrano, C	1
Castanheira, M; Diekema, DJ; Jones, RN; Messer, SA; Moet, GJ; Pfaller, MA	1
Arnold, TM; Dotson, E; Hage, CA; Sarosi, GA	1
Barre, O; Gay-Andrieu, F; Le Pape, P; Miegeville, M; Morio, F; Thierry, G	1
Ahlquist, AM; Chiller, T; Farley, MM; Harrison, LH; Iqbal, N; Lockhart, SR; Zimbeck, AJ	1
Ben-Ami, R; Kontoyiannis, DP; Lewis, RE	1
Boyken, L; Diekema, D; Hollis, R; Kroeger, J; Messer, S; Pfaller, M; Tendolkar, S	1
Arendrup, MC; Cuenca-Estrella, M; Delmas, G; Garcia-Effron, G; Gomez-Lopez, A; Park, S; Perlin, DS; Rodriguez-Tudela, JL	1
Andes, D; Bastulli, C; Chaturvedi, V; Diekema, DJ; Ghannoum, MA; Iqbal, N; Knapp, C; Lockhart, SR; Marchillo, K; Messer, S; Ostrosky-Zeichner, L; Paetznick, VL; Pfaller, MA; Ramani, R; Rodriguez, J; Sein, T; Walsh, TJ; Welshenbaugh, AR	1
Andes, D; Arendrup, MC; Brown, SD; Diekema, DJ; Lockhart, SR; Motyl, M; Perlin, DS; Pfaller, MA	1
Cantón, E; Espinel-Ingroff, A	1
Kofla, G; Ruhnke, M	1
Glöckner, A	1
Wilke, M	1
Arendrup, MC; Axner-Elings, M; Botero-Kleiven, S; Jensen, RH	1
Kuti, JL; Nicolau, DP; Sutherland, CA	1
Edlind, TD; Johnson, ME; Katiyar, SK	1
Le Guyader, N; Leverger, G	1
Andes, DR; Baddley, JW; Chiller, T; Ito, JI; Kauffman, CA; Kontoyiannis, DP; Lockhart, SR; Marr, KA; Pappas, PG; Walsh, TJ; Zimbeck, AJ	1
Bode-Böger, SM; Martens-Lobenhoffer, J; Rupprecht, V	1
Collins, MS; Cushion, MT	1
Alastruey-Izquierdo, A; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Livermore, J; Perlin, DS; Sharp, A; Warn, PA	1
Baltch, A; Bopp, LH; Michelsen, PP; Ritz, WJ; Smith, RP	1
Beiras-Fernandez, A; Heyn, J; Hinske, LC; Hinske, P; Weis, F	1
Barchiesi, F; Giannini, D; Manso, E; Orlando, F; Posteraro, B; Sanguinetti, M; Spreghini, E	1
Cortés L, JA; Russi N, JA	1
Fortún, J	1
Arendrup, MC; Goodwin, J; Hope, W; Howard, SJ; Jensen, RH; Perlin, DS	1
Alves, SH; Antunes, MS; Bandeira, LA; Denardi, LB; Mario, DA; Santurio, JM; Severo, LC	1
Andes, D; Castanheira, M; Diekema, D; Lepak, A; Pfaller, M	1
Cantón, E; Espinel-Ingroff, A; Hervás, D; Pemán, J	1
Aznar-Marín, P; García-Agudo, L; García-Martos, P; Marín-Casanova, P; Martos-Cañadas, J; Rodríguez-Iglesias, M	1
Katragkou, A; Kyrpitzi, D; Peshkova, P; Roilides, E; Simitsopoulou, M; Tasina, E; Velegraki, A; Walsh, TJ	1
Burgmann, H; Forstner, C; Poeppl, W; Schranz, H; Tobudic, S; Vychytil, A	1
Chan, TS; Chim, CS; Gill, H; Hwang, YY; Khong, PL; Kwong, YL; Leung, AY; Lie, AK; Loong, F; Sim, J; Tse, AC; Tse, E	1
Arendrup, MC; Bonfietti, LX; Bustamante, B; Canton, E; Chryssanthou, E; Cuenca-Estrella, M; Dannaoui, E; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Gaustad, P; Gonzalez, GM; Guarro, J; Lass-Flörl, C; Lockhart, SR; Meis, JF; Moore, CB; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; Pukinskas, SR; St-Germain, G; Szeszs, MW; Turnidge, J	1
Cleary, JD; Farley, JM; Kyle, PB; Stover, KR	1
Clancy, CJ; Nguyen, MH; Press, EG; Shields, RK; Updike, CL	1
Esposto, MC; Prigitano, A; Tortorano, AM	1
Bustamante, B; Canton, E; Diekema, DJ; Espinel-Ingroff, A; Fothergill, A; Fuller, J; Gonzalez, GM; Guarro, J; Lass-Flörl, C; Lockhart, SR; Martin-Mazuelos, E; Meis, JF; Ostrosky-Zeichner, L; Pelaez, T; Pfaller, MA; St-Germain, G; Turnidge, J	1
Carver, PL; Chen, S; Clancy, CJ; Clarke, LG; Eschenauer, GA; Hanson, KE; Klinker, KP; Kubin, CJ; Lam, SW; Morris, AJ; Nguyen, MH; Pasculle, WA; Potoski, BA; Shields, RK; Shoham, S; Vazquez, JA	1
Arendrup, MC; Cuenca-Estrella, M; Hope, WW; Lass-Flörl, C	1
Bernardo, SM; Lee, SA; Walraven, CJ; Wiederhold, NP	1
Gil-Gómez, I; Lorente-Fernández, L; Monte-Boquet, E; Poveda-Andrés, JL; Ruiz-Ramos, J; Salavert-Lleti, M	1
Kyrpitzi, D; Roilides, E; Simitsopoulou, M; Velegraki, A; Walsh, TJ	1
Beldavs, ZG; Bolden, CB; Chiller, TM; Cleveland, AA; Farley, MM; Harrison, LH; Iqbal, N; Kuykendall, RJ; Lockhart, SR; Park, BJ; Pham, CD; Schaffner, W	1
Cornely, OA; Franke, B; Glossmann, J; Heimann, SM; Kochanek, M; Langebartels, G; Padosch, SA; Reiner, M; Reuter, H; Seifert, H; Stippel, D; Vehreschild, JJ; Vehreschild, MJ; Vierzig, A; Wisplinghoff, H	1
Arens, C; Henrich, M; Koch, C; Li, L; Lichtenstern, C; Niemann, B; Rohrbach, S; Schulte, A; Uhle, F; Weigand, MA; Wolff, M	1
Cantón, E; Eraso, E; Gil-Alonso, S; Jauregizar, N; Quindós, G	1
Aarnoutse, RE; Brüggemann, RJ; Burger, DM; Lempers, VJ; Muilwijk, EW; Pickkers, P; Warris, A	1
Balbino, S; Caggiano, G; Coretti, C; De Giglio, O; Iatta, R; Lovero, G; Martinelli, D; Montagna, MT; Rosato, A	1
Juvvadi, PR; Lamoth, F; Moseley, MA; Muñoz, A; Read, ND; Soderblom, EJ; Steinbach, WJ	1
Cleary, JD; Stover, KR	1
Chlebicki, MP; Kwa, AL; Lee, W; Liew, YX; Ngan, CC; Tan, AL; Teo, J; Too, IA	1
Alvarez-Fernandez, M; Borrell Solé, N; Cantón, E; Carver, PL; Chen, SC; Echeverria, J; Eschenauer, G; Esperalba, J; Espinel-Ingroff, A; García García, I; Garcia-Effron, G; Getsinger, DL; Gómez-G de la Pedrosa, E; Gonzalez, GM; Govender, NP; Grancini, A; Guinea, J; Hanson, KE; Kidd, SE; Klinker, K; Kubin, CJ; Kus, JV; Linares, MJ; Lockhart, SR; Marco, F; Meletiadis, J; Merino, P; Morris, AJ; Pelaez, T; Pemán, J; Pérez Del Molino, L; Perlin, DS; Quindós, G; Rodriguez-Iglesias, M; Roselló Mayans, E; Rubio Calvo, C; Ruiz Pérez de Pipaon, M; Sánchez-Reus, F; Sanguinetti, M; Shields, R; Shoham, S; Turnidge, J; Wengenack, NL; Yagüe, G	1
Auzinger, G; Charbonneau, C; Graham, CN; Kantecki, M; Knox, HN; Playford, EG; Schlamm, H; Weinstein, D	1
Henrich, M; Koch, C; Lichtenstern, C; Uhle, F; Weigand, MA; Wolff, M	1
Bouza, E; Escribano, P; Guinea, J; Marcos-Zambrano, LJ	1
Perlin, DS	1
Ghannoum, M; Katragkou, A; Petraitis, V; Roilides, E; Walsh, TJ	1
Ge, T; Liao, S; Xu, G; Yang, J; Zhu, L	1
Akoumianaki, T; Albert, N; Andrianaki, A; Chamilos, G; Ioannou, P; Kontoyiannis, DP; Kyrmizi, I; Perlin, D; Samonis, G	1
Groeneveld, AB; Rijnders, BJ; van der Geest, PJ; Vonk, AG	1
Bouza, E; Escribano, P; Gómez-Perosanz, M; Guinea, J; Marcos-Zambrano, LJ; Zaragoza, O	1
Legendre, DP; Muzny, CA; Riley, TT; Swiatlo, E	1
Groeneveld, AB; Hunfeld, NG; Ladage, SE; van der Geest, PJ	1
Hsueh, PR; Wang, H; Xu, YC	1
Bouza, E; Escribano, P; Guinea, J; Marcos-Zambrano, LJ; Sánchez-Carrillo, C	1
Bordallo-Cardona, MÁ; Bouza, E; Cantón, R; de la Pedrosa, EG; Escribano, P; Guinea, J; Marcos-Zambrano, LJ	1
Barber, KE; Cretella, D; King, ST; Stover, KR	1
Chang, CC; Chen, SC; Slavin, MA	1
Arthur, I; Baird, R; Bak, N; Blyth, C; Botes, J; Chapman, B; Chen, S; Cheong, E; Cooley, L; George, CR; Goeman, E; Hajkowicz, K; Halliday, C; Heath, CH; Hofmeyr, A; Kalukottege, P; Keighley, C; Kennedy, K; Kesson, A; Kidd, S; Korman, TM; Leung, M; Liu, E; Macesic, N; Marriott, D; McMullan, B; Morrissey, CO; Pendle, S; Robson, J; Slavin, M; Sorrell, TC; Underwood, N; van Hal, S; Weeks, K	1
Aigner, M; Erbeznik, T; Gschwentner, M; Lass-Flörl, C	1
Charbonneau, C; Chen, YC; Lee, TY; Ou, HT	1
Majumdar, S; Patil, A	1
Cheung, YY; Hui, M	1
Courbin, V; Dannaoui, E; Jullien, V; Raffetin, A	1
Bordallo-Cardona, MÁ; Bouza, E; Cantón, R; de la Pedrosa, EG; Díaz-García, J; Escribano, P; Guinea, J; Marcos-Zambrano, LJ	1
Cai, WP; Chen, WS; Chen, XJ; He, Y; Hu, FY; Lei, HL; Li, LH; Song, WN; Tang, XP	1
Clancy, CJ; Healey, KR; Kline, EG; Kordalewska, M; Nguyen, MH; Perlin, DS; Shields, RK	1
Coad, BR; Giles, C; Griesser, HJ; Naderi, J; Saboohi, S	1
Bai, X; Feng, S; Gao, W; Li, J; Li, X; Quan, C; Xue, Y; Zhao, P; Zhao, Z; Zu, X	1
Buettner, B; Knoth, H; Langnaese, S; Scriba, GKE	1
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E	1
Chaftari, AM; Hachem, R; Kontoyiannis, DP; Raad, II; Reitzel, RA; Rosenblatt, J; Vargas-Cruz, N; Wilson Dib, R	1
Campany-Herrero, D; Gómez-Ganda, L; Terradas-Campanario, S	1
Brillowska-Dabrowska, A; Mroczyńska, M	1
Abastabar, M; Alastruey-Izquierdo, A; Hedayati, MT; Meletiadis, J; Nouripour-Sisakht, S; Rivero-Menendez, O; Sabino, R; Seyedmousavi, S; Siopi, M; Tavakoli, M; Valadan, R; van der Lee, H; Yazdani Charati, J; Zarrinfar, H	1
Bellmann, R; Joannidis, M; Oberacher, H; Schwärzler, B; Welte, R	1
Beer, R; Bellmann, R; Gasperetti, T; Jeske, M; Joannidis, M; Marx, J; Moser, P; Ortler, M; Pomaroli, A; Stern, R; Welte, R	1
Li, Y; Liu, D; Liu, X; Pan, Y	1
Kim, JH; Kim, MJ; Kim, SB; Sohn, JW; Suh, JW; Yoon, YK	1
Alvarez, ME; Cuenca-Estrella, M; Fortun, J; Gioia, F; Gomez-García de la Pedrosa, E; Gomez-Lopez, A; Martín-Davila, P; Moreno, S	1
Bot, JCJ; de Leeuw, DC; Hendriks, EJ; Overgaauw, AJC; Stoof, SP; van Dijk, K	1
Chen, J; Chu, Y; Han, X; Shang, H; Tian, S; Wang, Q; Zhou, B	1
Bellmann, R; Gasperetti, T; Joannidis, M; Marx, J; Moser, P; Welte, R	1
Coad, BR; Griesser, HJ; Naderi, J	1
Farooqi, J; Jabeen, K; Memon, S; Naqvi, SF; Zafar, A; Zafar, U	1
Bretagne, S; Desnos-Ollivier, M; Dromer, F; Lortholary, O	1
Aksaray, S; Turan, D	1
Farooqi, J; Ghanchi, NK; Jabeen, K; Memon, S; Zafar, U; Zaka, S	1
Balázs, B; Balogh, B; Bozó, A; Forgács, L; Kelentey, B; Kovács, R; Majoros, L; Tóth, Z	1
He, C; Kang, W; Li, J; Wang, T; Xu, Y; Yu, J; Zhang, G; Zhang, J; Zhao, Y	1

Reviews

34 review(s) available for anidulafungin and micafungin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Recent Progress in the Discovery of Antifungal Agents Targeting the Cell Wall. Journal of medicinal chemistry, 2020, 11-12, Volume: 63, Issue:21 Topics: Antifungal Agents; Cell Wall; Drug Discovery; Fungi; GPI-Linked Proteins; Humans; Mannans; Mycoses; Triterpenes	2020
New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. The oncologist, 2000, Volume: 5, Issue:2 Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Neoplasms; Opportunistic Infections; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2000
Clinical efficacy of echinocandin antifungals. Current opinion in infectious diseases, 2001, Volume: 14, Issue:6 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Mycoses; Peptides; Peptides, Cyclic	2001
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Revista iberoamericana de micologia, 2003, Volume: 20, Issue:4 Topics: Anidulafungin; Antifungal Agents; Echinocandins; Fungi; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycology; Peptides, Cyclic; Triazoles	2003
Pharmacokinetics/pharmacodynamics of echinocandins. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2004, Volume: 23, Issue:11 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic; Protein Binding; Tissue Distribution	2004
Antifungal agents in children. Pediatric clinics of North America, 2005, Volume: 52, Issue:3 Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole	2005
Echinocandin antifungals: review and update. Expert review of anti-infective therapy, 2006, Volume: 4, Issue:2 Topics: Anidulafungin; Animals; Antifungal Agents; beta-Glucans; Caspofungin; Echinocandins; Fungal Proteins; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic	2006
Echinocandins for candidemia in adults without neutropenia. The New England journal of medicine, 2006, Sep-14, Volume: 355, Issue:11 Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fungemia; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Peptides, Cyclic; Practice Guidelines as Topic	2006
Echinocandins in the management of invasive fungal infections, Part 2. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2006, Oct-01, Volume: 63, Issue:19 Topics: Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Catheterization; Critical Care; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Transplants	2006
The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications. Pharmacology, 2006, Volume: 78, Issue:4 Topics: Actins; Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candidiasis; Caspofungin; Drug Resistance, Microbial; Echinocandins; Humans; Lipopeptides; Lipoproteins; Liver; Liver Failure; Micafungin; Models, Chemical; Peptides, Cyclic; Rats	2006
The echinocandins. Pharmacotherapy, 2007, Volume: 27, Issue:3 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Candida albicans; Caspofungin; Cryptococcus; Echinocandins; Fungal Proteins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic	2007
A comparative evaluation of properties and clinical efficacy of the echinocandins. Expert opinion on pharmacotherapy, 2007, Volume: 8, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Enzyme Inhibitors; Glucosyltransferases; Humans; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Treatment Outcome	2007
A review of the new antifungals: posaconazole, micafungin, and anidulafungin. Journal of drugs in dermatology : JDD, 2007, Volume: 6, Issue:12 Topics: Administration, Oral; Anidulafungin; Antifungal Agents; Dermatomycoses; Echinocandins; Humans; Infusions, Intravenous; Lipopeptides; Lipoproteins; Micafungin; Triazoles	2007
[In vitro activity of anidulafungin. Comparison with the activity of other echinocandins]. Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 14 Topics: Anidulafungin; Antifungal Agents; Aspergillus; beta-Glucans; Candida; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungal Proteins; Glucosyltransferases; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity	2008
Echinocandins: the newest class of antifungals. The Annals of pharmacotherapy, 2009, Volume: 43, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Child; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses	2009
The echinocandins: three useful choices or three too many? International journal of antimicrobial agents, 2010, Volume: 35, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Caspofungin; Clinical Trials as Topic; Echinocandins; Humans; Lipopeptides; Micafungin	2010
Traditional and emerging antifungal therapies. Proceedings of the American Thoracic Society, 2010, Volume: 7, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Itraconazole; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole	2010
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2011, Volume: 14, Issue:3 Topics: Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Glucosyltransferases; Humans; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; Proteoglycans; Randomized Controlled Trials as Topic; Species Specificity; Treatment Outcome	2011
In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same? Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2 Topics: Anidulafungin; Candida; Candidiasis; Caspofungin; Drug Evaluation, Preclinical; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Glucosyltransferases; Humans; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity; Therapeutic Equivalency	2011
Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature. European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candidiasis, Invasive; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Molecular Structure	2011
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature. European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Clinical Trials as Topic; Drug Interactions; Echinocandins; Guidelines as Topic; Humans; Lipopeptides; Micafungin	2011
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin and its impact on use and costs: review of the literature. European journal of medical research, 2011, Apr-28, Volume: 16, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Cost-Benefit Analysis; Echinocandins; Humans; Lipopeptides; MEDLINE; Micafungin	2011
The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins. Recent patents on anti-infective drug discovery, 2012, Volume: 7, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus; Candida; Echinocandins; Humans; Lipopeptides; Micafungin; Patents as Topic	2012
[Echinocandins]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2011, Volume: 28, Issue:6 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Candida; Caspofungin; Clinical Trials as Topic; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2011
[Antifungal therapy update: new drugs and medical uses]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 5 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Candidiasis; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Early Diagnosis; Echinocandins; Humans; Immunocompromised Host; Lipopeptides; Micafungin; Mycoses; Randomized Controlled Trials as Topic; Salvage Therapy; Treatment Outcome; Triazoles	2011
Impact of special patient populations on the pharmacokinetics of echinocandins. Expert review of anti-infective therapy, 2015, Volume: 13, Issue:6 Topics: Adolescent; Adult; Anidulafungin; Antifungal Agents; Candida; Caspofungin; Child; Critical Illness; Drug Interactions; Echinocandins; Hematologic Diseases; Humans; Infant, Newborn; Kidney; Lipopeptides; Liver; Micafungin; Microbial Sensitivity Tests; Obesity	2015
Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:9 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Debridement; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Triazoles; Virulence	2016
Epidemiology of candidemia and antifungal susceptibility in invasive Candida species in the Asia-Pacific region. Future microbiology, 2016, Volume: 11 Topics: Anidulafungin; Antifungal Agents; Asia; Azoles; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidemia; Candidiasis; Candidiasis, Invasive; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Incidence; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Phenotype; Prevalence; Voriconazole	2016
New developments and directions in the clinical application of the echinocandins. Archives of toxicology, 2017, Volume: 91, Issue:4 Topics: Administration, Intravenous; Anidulafungin; Animals; Antifungal Agents; Biofilms; Candidiasis; Caspofungin; Drug Administration Schedule; Drug Interactions; Echinocandins; Humans; Lipopeptides; Micafungin	2017
Echinocandins in antifungal pharmacotherapy. The Journal of pharmacy and pharmacology, 2017, Volume: 69, Issue:12 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Mycoses	2017
Fungi-derived lipopeptide antibiotics developed since 2000. Peptides, 2019, Volume: 113 Topics: Anidulafungin; Anti-Infective Agents; Caspofungin; Depsipeptides; Echinocandins; Fungal Proteins; Fungi; Lipopeptides; Micafungin; Structure-Activity Relationship	2019
Pharmacokinetic/pharmacodynamics variability of echinocandins in critically ill patients: A systematic review and meta-analysis. Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:6 Topics: Anidulafungin; Antifungal Agents; Area Under Curve; Caspofungin; Critical Illness; Echinocandins; Humans; Invasive Fungal Infections; Micafungin	2020
Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC infectious diseases, 2020, Nov-11, Volume: 20, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Fluconazole; Humans; Micafungin; Prevalence	2020

Trials

1 trial(s) available for anidulafungin and micafungin

Article	Year
Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study. BMC infectious diseases, 2016, 09-15, Volume: 16 Topics: Anidulafungin; Antifungal Agents; APACHE; Candidiasis, Invasive; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Lipopeptides; Liver; Liver Function Tests; Male; Micafungin; Middle Aged; Regression Analysis; Retrospective Studies; Treatment Outcome	2016

Article

Year

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: a retrospective study.

BMC infectious diseases, 2016, 09-15, Volume: 16

Topics: Anidulafungin; Antifungal Agents; APACHE; Candidiasis, Invasive; Critical Illness; Echinocandins; Female; Humans; Intensive Care Units; Lipopeptides; Liver; Liver Function Tests; Male; Micafungin; Middle Aged; Regression Analysis; Retrospective Studies; Treatment Outcome

2016

Other Studies

133 other study(ies) available for anidulafungin and micafungin

Article	Year
Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Caspofungin; Echinocandins; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic	2007
Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:5 Topics: Amino Acid Sequence; Anidulafungin; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides, Cyclic; Protein Subunits	2007
Serum differentially alters the antifungal properties of echinocandin drugs. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Aspergillus fumigatus; Candida albicans; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Lipoproteins; Micafungin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides, Cyclic; Serum	2007
Paradoxical effect of Echinocandins across Candida species in vitro: evidence for echinocandin-specific and candida species-related differences. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Culture Media; Fungemia; Humans; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Species Specificity	2007
A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Amino Acid Sequence; Amino Acid Substitution; Aspergillus fumigatus; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Glucosyltransferases; Molecular Sequence Data; Proline; Sequence Homology, Amino Acid; Serine	2007
Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:11 Topics: Anidulafungin; Aspergillus; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Protein Binding; Serum	2007
Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Spores, Fungal	2008
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Spain; Species Specificity	2008
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:6 Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fatal Outcome; Female; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Microbial Sensitivity Tests; Mutation	2008
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida; Candidiasis; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Enzyme Inhibitors; Fungal Proteins; Gene Expression; Genes, Fungal; Glucosyltransferases; Humans; Membrane Proteins; Molecular Sequence Data; Mutagenesis, Site-Directed; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Species Specificity	2008
Pharmacokinetics and tissue distribution of anidulafungin in rats. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Anidulafungin; Animals; Antifungal Agents; Autoradiography; Candidiasis; Carbon Radioisotopes; Echinocandins; Humans; Infusions, Intravenous; Kidney; Liver; Lung; Male; Rats; Rats, Inbred F344; Spleen; Tissue Distribution	2008
In vitro susceptibilities of invasive isolates of Candida species: rapid increase in rates of fluconazole susceptible-dose dependent Candida glabrata isolates. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Fluconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Susceptibility testing and molecular classification of Paecilomyces spp. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; Echinocandins; Itraconazole; Microbial Sensitivity Tests; Paecilomyces; Phylogeny	2008
Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Adult; Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida glabrata; Candidiasis; Caspofungin; DNA Primers; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Lipopeptides	2008
Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Anidulafungin; Antifungal Agents; Base Sequence; Candida albicans; Candidiasis; Caspofungin; DNA Mutational Analysis; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Point Mutation	2008
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged	2008
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:1 Topics: Anidulafungin; Candida albicans; Caspofungin; Echinocandins; Fungal Proteins; Glucosyltransferases; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2009
Differential effects of inhibiting chitin and 1,3-{beta}-D-glucan synthesis in ras and calcineurin mutants of Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Aminoglycosides; Antifungal Agents; Aspergillus fumigatus; beta-Glucans; Calcineurin; Caspofungin; Cell Wall; Chitin; Echinocandins; Fluorescent Dyes; Fungal Proteins; Genes, Fungal; Genes, ras; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Mutation; Signal Transduction	2009
In vitro activities of various antifungal drugs against Aspergillus terreus: Global assessment using the methodology of the European committee on antimicrobial susceptibility testing. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Antifungal Agents; Aspergillosis; Aspergillus; DNA, Fungal; Humans; Microbial Sensitivity Tests; Soil Microbiology	2009
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Antifungal Agents; Candida; Candidiasis; Data Collection; Disease Susceptibility; Greece; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies	2009
Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Acremonium; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Echinocandins; Fungi; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Penicillium; Scedosporium; Spain	2009
In vitro activity of micafungin against planktonic and sessile Candida albicans isolates. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:6 Topics: Antifungal Agents; Biofilms; Candida albicans; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Plankton	2009
In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2009
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9 Topics: Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Glucosyltransferases; Reverse Transcriptase Polymerase Chain Reaction	2009
Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Aged; Antifungal Agents; Echinocandins; Fatal Outcome; Geotrichosis; Geotrichum; Humans; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Neutropenia	2009
Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Male; Micafungin; Mice	2009
Comparison of anidulafungin MICs determined by the clinical and laboratory standards institute broth microdilution method (M27-A3 document) and Etest for Candida species isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Microbial Sensitivity Tests; Reference Standards	2010
In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microbiological Techniques; Time Factors	2010
Novel FKS mutations associated with echinocandin resistance in Candida species. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5 Topics: Adult; Antifungal Agents; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Echinocandins; Female; Glucosyltransferases; Humans; Male; Middle Aged; Mutation	2010
Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; In Vitro Techniques; Lipopeptides; Madurella; Micafungin; Microbial Sensitivity Tests; Mycetoma	2010
Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Amino Acid Sequence; Amino Acid Substitution; Antifungal Agents; Base Sequence; Candida; Candida albicans; Candida glabrata; Candidiasis; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Genes, Fungal; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Homology, Amino Acid; Species Specificity	2010
In vivo comparison of the pharmacodynamic targets for echinocandin drugs against Candida species. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Female; Kidney; Lipopeptides; Micafungin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Protein Binding; Species Specificity	2010
Antifungal susceptibility profile of human-pathogenic species of Lichtheimia. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7 Topics: Amphotericin B; Antifungal Agents; Humans; Microbial Sensitivity Tests; Mucorales; Pyrimidines; Triazoles; Voriconazole	2010
The echinocandins, first novel class of antifungals in two decades: will they live up to their promise? International journal of clinical practice, 2001, Volume: 55, Issue:9 Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Cell Wall; Echinocandins; Fungi; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides; Peptides, Cyclic; Randomized Controlled Trials as Topic	2001
Echinocandins: ask not what they can do for esophageal candidiasis--ask what studies of esophageal candidiasis can do for them. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Sep-15, Volume: 39, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candidiasis; Caspofungin; Echinocandins; Esophageal Diseases; Fungal Proteins; Humans; Lipopeptides; Lipoproteins; Micafungin; Peptides, Cyclic	2004
Advances in antifungal therapy. The Pediatric infectious disease journal, 2005, Volume: 24, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Animals; Antifungal Agents; Caspofungin; Child; Child, Preschool; Clinical Trials as Topic; Echinocandins; Fungal Proteins; Humans; Infant; Infant, Newborn; Lipopeptides; Lipoproteins; Micafungin; Middle Aged; Mycoses; Peptides, Cyclic; Pyrimidines; Thiazoles; Treatment Outcome; Triazoles; Voriconazole	2005
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance. Journal of clinical microbiology, 2008, Volume: 46, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests	2008
Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests	2008
Combination echinocandin-polyene treatment of murine mucormycosis. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4 Topics: Amphotericin B; Anidulafungin; Animals; Antifungal Agents; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Humans; Lipopeptides; Lipoproteins; Liposomes; Male; Micafungin; Mice; Mice, Inbred BALB C; Mucormycosis; Polyenes; Rhizopus; Treatment Outcome	2008
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. Journal of clinical microbiology, 2008, Volume: 46, Issue:7 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Reference Standards; Reproducibility of Results; Sensitivity and Specificity	2008
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. Journal of clinical microbiology, 2008, Volume: 46, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Clinical Trials as Topic; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Statistics as Topic; Treatment Outcome	2008
Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2009, Volume: 15, Issue:3 Topics: Anidulafungin; Antifungal Agents; Burn Units; Burns; Candida; Candidiasis; Carrier State; Caspofungin; Echinocandins; Environmental Microbiology; Fungal Proteins; Genotype; Glucosyltransferases; Health Personnel; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Sequence Analysis, DNA	2009
In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method. Journal of clinical microbiology, 2009, Volume: 47, Issue:10 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Echinocandins; Humans; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2009
Determination of Echinocandin MICs for Candida species in less than 8 hours: comparison of the rapid susceptibility assay with the Clinical and Laboratory Standards Institute's broth microdilution assay. Journal of clinical microbiology, 2009, Volume: 47, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Culture Media; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity	2009
Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Culture Media; Echinocandins; Indicator Dilution Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Reference Standards	2010
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. Journal of clinical microbiology, 2010, Volume: 48, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2010
Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins. Medical mycology, 2010, Volume: 48, Issue:6 Topics: Anidulafungin; Antifungal Agents; Aspergillus; Caspofungin; Echinocandins; Fusarium; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycology	2010
Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. Journal of clinical microbiology, 2010, Volume: 48, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2010
[Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®]. Pathologie-biologie, 2011, Volume: 59, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidemia; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Female; France; Fungal Proteins; Glycosyltransferases; Hospitals, University; Humans; In Vitro Techniques; Infant; Infant, Newborn; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Ribotyping; Species Specificity; Young Adult	2011
FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Glucosyltransferases; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction	2010
In vitro interactions among echinocandins against Aspergillus fumigatus: lack of concordance among methods. Medical mycology, 2011, Volume: 49, Issue:3 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Drug Interactions; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2011
Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin. Journal of clinical microbiology, 2011, Volume: 49, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2011
Echinocandin susceptibility testing of Candida spp. Using EUCAST EDef 7.1 and CLSI M27-A3 standard procedures: analysis of the influence of bovine serum albumin supplementation, storage time, and drug lots. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Caspofungin; Cattle; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Serum Albumin, Bovine	2011
Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:4 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Drug Combinations; Echinocandins; Enzyme-Linked Immunosorbent Assay; Inhibitory Concentration 50; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2011
Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden. Journal of clinical microbiology, 2011, Volume: 49, Issue:7 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fungal Proteins; Fungemia; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation, Missense; Sweden	2011
Development of an HPLC method for the determination of anidulafungin in human plasma and saline. Journal of chromatographic science, 2011, Volume: 49, Issue:5 Topics: Anidulafungin; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Stability; Echinocandins; Humans; Least-Squares Analysis; Lipopeptides; Micafungin; Reproducibility of Results; Sensitivity and Specificity; Sodium Chloride; Tandem Mass Spectrometry	2011
New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium species. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8 Topics: Anidulafungin; Antifungal Agents; Base Sequence; beta-Glucans; Candida glabrata; Caspofungin; Cell Wall; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Lipopeptides; Membrane Proteins; Micafungin; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Proteoglycans; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Scedosporium; Sequence Alignment; Sequence Analysis, DNA	2011
[Echinocandins in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2011, Volume: 18 Suppl 1 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis, Invasive; Caspofungin; Child; Echinocandins; Evidence-Based Medicine; Humans; Injections, Intravenous; Lipopeptides; Micafungin; Mycoses; Treatment Outcome	2011
In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8 Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Transplantation	2011
Determination of micafungin and anidulafungin in human plasma: UV- or mass spectrometric quantification? Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Jul-15, Volume: 879, Issue:22 Topics: Anidulafungin; Antifungal Agents; Calibration; Chromatography, Reverse-Phase; Drug Monitoring; Drug Stability; Echinocandins; Humans; Least-Squares Analysis; Lipopeptides; Micafungin; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Tandem Mass Spectrometry	2011
Susceptibility of Pneumocystis to echinocandins in suspension and biofilm cultures. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10 Topics: Adenosine Triphosphate; Anidulafungin; Animals; Antifungal Agents; Biofilms; Caspofungin; Drug Resistance, Fungal; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pneumocystis carinii; Pneumocystis Infections; Rats	2011
Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:10 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Humans; Lipopeptides; Male; Micafungin; Mice; Microbial Sensitivity Tests; Neutropenia	2011
Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis. Diagnostic microbiology and infectious disease, 2011, Volume: 71, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2011
Comparative effects of micafungin, caspofungin, and anidulafungin against a difficult-to-treat fungal opportunistic pathogen, Candida glabrata. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:3 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Female; Humans; Lipopeptides; Micafungin; Mice; Microbial Sensitivity Tests; Mutation	2012
Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Biological Availability; Candida glabrata; Candidiasis; Caspofungin; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Genes, Fungal; Glucosyltransferases; Humans; Kidney; Lipopeptides; Micafungin; Mice; Microbial Sensitivity Tests; Mutation	2012
The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates. Memorias do Instituto Oswaldo Cruz, 2012, Volume: 107, Issue:3 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2012
Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Candida glabrata; Candidiasis, Invasive; Caspofungin; Echinocandins; Female; Fungal Proteins; Glucosyltransferases; Humans; Kidney; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Mutation	2012
Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Colony Count, Microbial; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Viability; Time Factors	2013
Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2012, Volume: 25, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Caspofungin; Colorimetry; Dose-Response Relationship, Drug; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Species Specificity; Time Factors	2012
Species-specific and drug-specific differences in susceptibility of Candida biofilms to echinocandins: characterization of less common bloodstream isolates. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Candidemia; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Plankton; Species Specificity	2013
Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids. Mycoses, 2013, Volume: 56, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candida albicans; Caspofungin; Dialysis Solutions; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microbial Viability; Peritoneal Dialysis; Time Factors	2013
Breakthrough invasive fungal diseases during echinocandin treatment in high-risk hospitalized hematologic patients. Annals of hematology, 2014, Volume: 93, Issue:3 Topics: Adenine Nucleotides; Adult; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Arabinonucleosides; Candida; Candidiasis, Invasive; Caspofungin; China; Clofarabine; Cohort Studies; Cross Infection; Echinocandins; Fusariosis; Fusarium; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Lipopeptides; Lung Diseases, Fungal; Micafungin; Retrospective Studies; Risk Factors	2014
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Europe; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; North America; Observer Variation; South America; Species Specificity	2013
Cardiac toxicity of some echinocandin antifungals. Expert opinion on drug safety, 2014, Volume: 13, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; Dose-Response Relationship, Drug; Echinocandins; Lipopeptides; Male; Micafungin; Microscopy, Electron, Transmission; Mitochondria, Heart; Myocardial Contraction; Myofibrils; Rats; Rats, Sprague-Dawley; Toxicity Tests	2014
Anidulafungin and micafungin MIC breakpoints are superior to that of caspofungin for identifying FKS mutant Candida glabrata strains and Echinocandin resistance. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2013
Comparison of effects of human serum and horse serum on in vitro susceptibility testing of echinocandins. Journal of chemotherapy (Florence, Italy), 2014, Volume: 26, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Caspofungin; Echinocandins; Horses; Humans; In Vitro Techniques; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Serum	2014
Frequency of fks mutations among Candida glabrata isolates from a 10-year global collection of bloodstream infection isolates. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation	2014
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Echinocandins; Europe; Fungal Proteins; Gene Expression; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; North America; South America	2014
Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:4 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2014
EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole. Mycoses, 2014, Volume: 57, Issue:6 Topics: Anidulafungin; Animals; Antifungal Agents; Candida; Echinocandins; Europe; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2014
Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. Medical mycology, 2014, Volume: 52, Issue:2 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Candidiasis; Caspofungin; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Membrane Proteins; Micafungin; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron; Mutant Proteins; Staining and Labeling	2014
Anidulafungin-induced alopecia. The Annals of pharmacotherapy, 2014, Volume: 48, Issue:5 Topics: Adult; Alopecia; Anidulafungin; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Echinocandins; Female; Fluconazole; Humans; Lipopeptides; Micafungin	2014
Caspofungin at catheter lock concentrations eradicates mature biofilms of Candida lusitaniae and Candida guilliermondii. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candida albicans; Caspofungin; Catheters; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Plankton	2014
Role of FKS Mutations in Candida glabrata: MIC values, echinocandin resistance, and multidrug resistance. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Fungal Proteins; Glucosyltransferases; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation; United States	2014
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candidemia; Caspofungin; Child; Child, Preschool; Echinocandins; Female; Fluconazole; Health Care Costs; Hospitalization; Humans; Infant; Intensive Care Units; Lipopeptides; Male; Micafungin; Middle Aged; Treatment Outcome; Young Adult	2015
Cardiac effects of echinocandins after central venous administration in adult rats. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3 Topics: Anidulafungin; Animals; Antifungal Agents; Caspofungin; DNA, Mitochondrial; Echinocandins; Heart Failure; Heart Ventricles; Hemodynamics; Lipopeptides; Male; Micafungin; Rats; Rats, Inbred Lew	2015
In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:6 Topics: Anidulafungin; Antifungal Agents; Candida; Candida glabrata; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2015
Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods. BMC microbiology, 2015, May-20, Volume: 15 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Hospitals, University; Humans; Italy; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2015
Calcium-Mediated Induction of Paradoxical Growth following Caspofungin Treatment Is Associated with Calcineurin Activation and Phosphorylation in Aspergillus fumigatus. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Calcineurin; Calcium; Caspofungin; Echinocandins; Egtazic Acid; Fungal Proteins; Lipopeptides; Micafungin; Phosphorylation	2015
Cardiac response to centrally administered echinocandin antifungals. The Journal of pharmacy and pharmacology, 2015, Volume: 67, Issue:9 Topics: Anidulafungin; Animals; Antifungal Agents; Blood Pressure; Cardiac Output; Caspofungin; Echinocandins; Heart; Heart Rate; Lipopeptides; Male; Micafungin; Rats; Rats, Sprague-Dawley	2015
Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution. BMC infectious diseases, 2015, Jul-03, Volume: 15 Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; beta-Glucans; Candida; Candida albicans; Candida glabrata; Candidiasis; Candidiasis, Invasive; Carrier State; Caspofungin; Critical Care; Echinocandins; Female; Fluconazole; Humans; Incidence; Intensive Care Units; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Sensitivity and Specificity; Singapore; Tertiary Care Centers; Voriconazole	2015
Multicenter study of epidemiological cutoff values and detection of resistance in Candida spp. to anidulafungin, caspofungin, and micafungin using the Sensititre YeastOne colorimetric method. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation	2015
Cost-effectiveness analysis of anidulafungin for the treatment of candidaemia and other forms of invasive candidiasis. BMC infectious diseases, 2015, Oct-26, Volume: 15 Topics: Anidulafungin; Antifungal Agents; Candidemia; Candidiasis, Invasive; Caspofungin; Cost-Benefit Analysis; Drug Costs; Echinocandins; Fluconazole; Humans; Intensive Care Units; Length of Stay; Lipopeptides; Micafungin; Models, Economic; Treatment Outcome; United Kingdom	2015
Cardiac Effects of Echinocandins in Endotoxemic Rats. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Anidulafungin; Animals; Antifungal Agents; Cardiac Output; Cardiac Volume; Caspofungin; Echinocandins; Endotoxemia; Female; Heart; Hemorheology; Humans; Lipopeptides; Lipopolysaccharides; Male; Micafungin; Myocytes, Cardiac; Primary Cell Culture; Rats; Rats, Inbred Lew; Shock, Septic	2016
Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production. Medical mycology, 2016, Volume: 54, Issue:2 Topics: Anidulafungin; Antifungal Agents; Biofilms; Biomass; Candida albicans; Candidemia; Caspofungin; Echinocandins; Gentian Violet; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Oxidation-Reduction; Portugal; Staining and Labeling; Tetrazolium Salts	2016
Echinocandin Resistance in Candida. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Antifungal Agents; Azoles; Candida; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Multiple, Fungal; Echinocandins; Glucosyltransferases; Humans; Intraabdominal Infections; Lipopeptides; Micafungin; Mutation	2015
The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Dec-01, Volume: 61 Suppl 6 Topics: Anidulafungin; Animals; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Disease Models, Animal; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Vascular Access Devices	2015
Assessment of echinocandin regimens by pharmacokinetic/pharmacodynamic analysis against Candida spp. in paediatric patients. International journal of antimicrobial agents, 2015, Volume: 46, Issue:6 Topics: Adolescent; Adult; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Caspofungin; Child; Child, Preschool; Dose-Response Relationship, Drug; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Monte Carlo Method	2015
Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae. Antimicrobial agents and chemotherapy, 2015, Dec-07, Volume: 60, Issue:3 Topics: Albumins; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Culture Media; Echinocandins; Humans; Hyphae; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Voriconazole	2015
Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections. Mycoses, 2016, Volume: 59, Issue:3 Topics: Administration, Intravenous; Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Critical Illness; Echinocandins; Female; Fluconazole; Humans; Intensive Care Units; Lipopeptides; Male; Micafungin; Middle Aged; Multivariate Analysis; Retrospective Studies	2016
Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2016
Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candida tropicalis; Candidemia; Candidiasis; Caspofungin; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2017
In Vitro Exposure to Increasing Micafungin Concentrations Easily Promotes Echinocandin Resistance in Candida glabrata Isolates. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:2 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation	2017
Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp. Journal of medical microbiology, 2016, Volume: 65, Issue:12 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidiasis; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Respiratory System; Urine	2016
Changing epidemiology of candidaemia in Australia. The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4 Topics: Anidulafungin; Antifungal Agents; Australia; Azoles; Candida; Candida glabrata; Candida tropicalis; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Humans; Incidence; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Triazoles; Voriconazole	2017
Etest and Sensititre YeastOne Susceptibility Testing of Echinocandins against Candida Species from a Single Center in Austria. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Anidulafungin; Antifungal Agents; Austria; Candida; Candidiasis; Caspofungin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin	2017
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species. BMC infectious diseases, 2017, 07-10, Volume: 17, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candidemia; Candidiasis, Invasive; Caspofungin; Cost-Benefit Analysis; Echinocandins; Economics, Pharmaceutical; Fluconazole; Humans; Lipopeptides; Micafungin; Taiwan; Treatment Outcome	2017
Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Aminoglycosides; Anidulafungin; Animals; Antifungal Agents; Candida albicans; Candidiasis; Chitin Synthase; Drug Combinations; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Glucosyltransferases; Humans; Lipopeptides; Micafungin; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests	2017
Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:1 Topics: Anidulafungin; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Aspergillus nidulans; Aspergillus niger; Drug Combinations; Drug Resistance, Fungal; Humans; Micafungin; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles	2018
Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata. Medical mycology, 2018, Oct-01, Volume: 56, Issue:7 Topics: Anidulafungin; Animals; Antifungal Agents; Candida glabrata; Candidiasis; Disease Models, Animal; DNA Mutational Analysis; Drug Resistance, Fungal; Glucosyltransferases; Lepidoptera; Micafungin; Mutation; Survival Analysis	2018
Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:6 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Echinocandins; HIV Infections; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mycoses; Reagent Kits, Diagnostic; Talaromyces; Voriconazole	2018
Spontaneous Mutational Frequency and Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Fungal Proteins; Gene Expression; Genetic Loci; Glucosyltransferases; Humans; Micafungin; Microbial Sensitivity Tests; Mutation Rate	2019
Surface coatings with covalently attached anidulafungin and micafungin prevent Candida albicans biofilm formation. The Journal of antimicrobial chemotherapy, 2019, 02-01, Volume: 74, Issue:2 Topics: Anidulafungin; Antifungal Agents; Biofilms; Candida albicans; Immobilized Proteins; Micafungin; Surface Properties	2019
Differential pulse polarographic investigation of micafungin and anidulafungin using a dropping mercury electrode. Die Pharmazie, 2019, 01-01, Volume: 74, Issue:1 Topics: Anidulafungin; Antifungal Agents; Electrochemistry; Electrodes; Hydrogen-Ion Concentration; Mercury; Micafungin; Polarography	2019
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia. Scientific reports, 2019, 03-07, Volume: 9, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult	2019
Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:7 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Biofilms; Candida; Caspofungin; Catheter-Related Infections; Catheters; Citric Acid; Ethanol; Fluconazole; Micafungin; Nitroglycerin; Pharmaceutical Solutions; Voriconazole	2019
Physicochemical characterization of micafungin and anidulafungin for its nebulized administration. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2019, Sep-01, Volume: 43, Issue:5 Topics: Administration, Inhalation; Anidulafungin; Antifungal Agents; Chlorides; Humans; Hydrogen-Ion Concentration; Micafungin; Nebulizers and Vaporizers; Osmometry; Viscosity	2019
First report on echinocandin resistant Polish Candida isolates. Acta biochimica Polonica, 2019, Sep-12, Volume: 66, Issue:3 Topics: Anidulafungin; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Micafungin; Microbial Sensitivity Tests; Poland	2019
Genetic diversity and antifungal susceptibility patterns of Aspergillus nidulans complex obtained from clinical and environmental sources. Mycoses, 2020, Volume: 63, Issue:1 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Aspergillus nidulans; Azoles; Cross Infection; Environmental Microbiology; Genetic Variation; Greece; Humans; Iran; Micafungin; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Epidemiology; Netherlands; Phylogeny; Phylogeography; Portugal; Spain; Tubulin	2020
Quantification of anidulafungin and micafungin in human body fluids by high performance-liquid chromatography with UV-detection. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020, Feb-15, Volume: 1139 Topics: Anidulafungin; Ascitic Fluid; Candidiasis, Invasive; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Limit of Detection; Linear Models; Micafungin; Reproducibility of Results; Solid Phase Extraction; Spectrophotometry, Ultraviolet	2020
Anidulafungin and Micafungin Concentrations in Cerebrospinal Fluid and in Cerebral Cortex. Antimicrobial agents and chemotherapy, 2020, 06-23, Volume: 64, Issue:7 Topics: Adult; Anidulafungin; Antifungal Agents; Cerebral Cortex; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests	2020
Anidulafungin Versus Micafungin in the Treatment of Candidemia in Adult Patients. Mycopathologia, 2020, Volume: 185, Issue:4 Topics: Aged; Anidulafungin; Antifungal Agents; Candidemia; Echinocandins; Female; Humans; Lipopeptides; Male; Micafungin; Middle Aged; Retrospective Studies	2020
Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 101 Topics: Adult; Anidulafungin; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Critical Illness; Echinocandins; Female; Humans; Male; Micafungin; Microbial Sensitivity Tests; Peritonitis; Prospective Studies	2020
Case report: Candida krusei spondylitis in an immunocompromised patient. BMC infectious diseases, 2020, Oct-08, Volume: 20, Issue:1 Topics: Aged; Anidulafungin; Antifungal Agents; Candida; Candidemia; Candidiasis; Humans; Immunocompromised Host; Induction Chemotherapy; Male; Micafungin; Spondylitis; Treatment Outcome; Voriconazole	2020
Human Tissue Distribution of Anidulafungin and Micafungin. Antimicrobial agents and chemotherapy, 2021, 06-17, Volume: 65, Issue:7 Topics: Anidulafungin; Antifungal Agents; Echinocandins; Humans; Lipopeptides; Micafungin; Tissue Distribution	2021
Assessment of nonreleasing antifungal surface coatings bearing covalently attached pharmaceuticals. Biointerphases, 2021, 11-18, Volume: 16, Issue:6 Topics: Anidulafungin; Antifungal Agents; Echinocandins; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Pharmaceutical Preparations	2021
Antifungal susceptibility profile of invasive Journal of medical microbiology, 2021, Volume: 70, Issue:12 Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candida glabrata; Candidemia; Caspofungin; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Micafungin; Pakistan; Retrospective Studies; Tertiary Care Centers	2021
Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations. Antimicrobial agents and chemotherapy, 2022, 05-17, Volume: 66, Issue:5 Topics: Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Caspofungin; Drug Resistance, Fungal; Echinocandins; Humans; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mutation	2022
[One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?] Mikrobiyoloji bulteni, 2022, Volume: 56, Issue:3 Topics: Anidulafungin; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Humans; Micafungin; Microbial Sensitivity Tests; Mycology; Voriconazole	2022
Analysis of fks1 and fks2 gene mutations in invasive Candida glabrata strains from Pakistan. Mycoses, 2023, Volume: 66, Issue:1 Topics: Anidulafungin; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fungal Proteins; Glucosyltransferases; Humans; Micafungin; Microbial Sensitivity Tests; Mutation; Pakistan	2023
The In Vitro Activity of Fluconazole, Amphotericin B and Echinocandins Against Cyberlindnera fabianii Planktonic Cells and Biofilms. Mycopathologia, 2023, Volume: 188, Issue:1-2 Topics: Amphotericin B; Anidulafungin; Biofilms; Caspofungin; Echinocandins; Fluconazole; Micafungin	2023
Rapid automated antifungal susceptibility testing system for yeasts based on growth characteristics. Frontiers in cellular and infection microbiology, 2023, Volume: 13 Topics: Anidulafungin; Antifungal Agents; Candida; Caspofungin; Fluconazole; Micafungin; Microbial Sensitivity Tests; Reproducibility of Results; Voriconazole; Yeasts	2023